These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 9406240)
1. DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Rauth AM; Goldberg Z; Misra V Oncol Res; 1997; 9(6-7):339-49. PubMed ID: 9406240 [TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528 [TBL] [Abstract][Full Text] [Related]
3. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes. Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280 [TBL] [Abstract][Full Text] [Related]
4. Suggested mechanism for the modulation of the activity of NAD(P)H:quinone acceptor oxidoreductase (DT-diaphorase) by menadione: interpretation of the effect of menadione on 5'-[p-(Fluorosulfonyl)benzoyl]adenosine labeling of rat liver NAD(P)H:quinone acceptor oxidoreductase. Chen S; Liu XF Mol Pharmacol; 1992 Sep; 42(3):545-48. PubMed ID: 1406605 [TBL] [Abstract][Full Text] [Related]
5. Demonstration of the activation of prodrug CB 1954 using human DT-diaphorase mutant Q104Y-transfected MDA-MB-231 cells and mouse xenograft model. Wu K; Eng E; Knox R; Chen S Arch Biochem Biophys; 2001 Jan; 385(1):203-8. PubMed ID: 11361019 [TBL] [Abstract][Full Text] [Related]
6. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Begleiter A; Leith MK; Curphey TJ; Doherty GP Oncol Res; 1997; 9(6-7):371-82. PubMed ID: 9406243 [TBL] [Abstract][Full Text] [Related]
7. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase. Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423 [TBL] [Abstract][Full Text] [Related]
8. Reaction of rat liver DT-diaphorase (NAD(P)H:quinone acceptor reductase) with 5'-[p-(fluorosulfonyl)benzoyl]-adenosine. Liu XF; Yuan H; Haniu M; Iyanagi T; Shively JE; Chen SA Mol Pharmacol; 1989 Jun; 35(6):818-22. PubMed ID: 2499768 [TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Ross D; Siegel D Methods Enzymol; 2004; 382():115-44. PubMed ID: 15047100 [No Abstract] [Full Text] [Related]
10. Increased NAD(P)H:(quinone-acceptor)oxidoreductase activity is associated with density-dependent growth inhibition of normal but not transformed cells. Schlager JJ; Hoerl BJ; Riebow J; Scott DP; Gasdaska P; Scott RE; Powis G Cancer Res; 1993 Mar; 53(6):1338-42. PubMed ID: 8443814 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of NAD(P)H:quinone reductase: Ab initio studies of reduced flavin. Cavelier G; Amzel LM Proteins; 2001 Jun; 43(4):420-32. PubMed ID: 11340659 [TBL] [Abstract][Full Text] [Related]
12. Cigarette smoking is a determinant of DT-diaphorase gene expression in human non-small cell lung carcinoma. Gasdaska PY; Powis G; Hyman P; Fisher H Cancer Res; 1993 Nov; 53(22):5458-61. PubMed ID: 8221686 [TBL] [Abstract][Full Text] [Related]
13. Gene targeting of DT-diaphorase in mouse embryonic stem cells: establishment of null mutant and its mitomycin C-resistance. Yoshida T; Tsuda H Biochem Biophys Res Commun; 1995 Sep; 214(2):701-8. PubMed ID: 7677784 [TBL] [Abstract][Full Text] [Related]
14. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state. Mohora M Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570 [TBL] [Abstract][Full Text] [Related]
15. Oxidation of dopamine to aminochrome as a mechanism for neurodegeneration of dopaminergic systems in Parkinson's disease. Possible neuroprotective role of DT-diaphorase. Graumann R; Paris I; Martinez-Alvarado P; Rumanque P; Perez-Pastene C; Cardenas SP; Marin P; Diaz-Grez F; Caviedes R; Caviedes P; Segura-Aguilar J Pol J Pharmacol; 2002; 54(6):573-9. PubMed ID: 12866711 [TBL] [Abstract][Full Text] [Related]
16. pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin. Siegel D; Beall H; Kasai M; Arai H; Gibson NW; Ross D Mol Pharmacol; 1993 Dec; 44(6):1128-34. PubMed ID: 8264549 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Misra V; Grondin A; Klamut HJ; Rauth AM Br J Cancer; 2000 Oct; 83(8):998-1002. PubMed ID: 10993645 [TBL] [Abstract][Full Text] [Related]
18. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Workman P Oncol Res; 1994; 6(10-11):461-75. PubMed ID: 7620214 [TBL] [Abstract][Full Text] [Related]
19. In vivo exposure of Dreissena polymorpha mussels to the quinones menadione and lawsone: menadione is more toxic to mussels than lawsone. Osman AM; Rotteveel S; den Besten PJ; van Noort PC J Appl Toxicol; 2004; 24(2):135-41. PubMed ID: 15052609 [TBL] [Abstract][Full Text] [Related]
20. Distribution of DT-diaphorase and reduced nicotinamide adenine dinucleotide phosphate: cytochrome p450 oxidoreductase in bladder tissues and tumors. Li D; Gan Y; Wientjes MG; Badalament RA; Au JL J Urol; 2001 Dec; 166(6):2500-5. PubMed ID: 11696818 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]